Please log in
to access more information


User name and Password not recognised

Home Page > The Company > Management


Étienne Binant Etienne Binant
Chief Executive Officer

Étienne Binant, Chief executive officer, has more than 15 years of experience in the world of strategic consulting and finance applied to innovation (Medtech and NTIC). Etienne has organized more than 20 venture capital operations over the last 5 years. Previously, Etienne was the leader of transnational private equity operations between France and the United States. He also administered for four years the MJC in IDF, one of the main socio-cultural associations of France. Etienne led Biom'up's efforts in the success of its pivotal study for Hemoblast and raised over € 100 million for the Company through private financing and its IPO in October 2017.

William D. Spotnitz William D. Spotnitz M.D., M.B.A.
Chief Medical Officer

Dr. Spotnitz is an international expert in the field of hemostats, sealants, and adhesives with more than 70 publications in this area of study. He has extensive experience in surgical needs assessment, device design, preclinical experimentation, clinical trials, FDA regulatory affairs, product education, and marketing to health professionals having collaborated with more than 30 different companies in these areas.

Valérie Centis Valérie Centis
Executive Vice President & Chief Scientific Officer

With a Ph.D. in Biotechnological and Chemical Engineering from Sherbrooke University and a Biomedical Science degree from the University of Montreal, Valerie Centis joined Biom'up in 2010 as a R&D and Regulatory Project Manager. As Chief Scientific Officer, she now manages FDA and EC product design in conformity with regulatory requirements, overseeing various teams and international collaborators.

Thierry Darnis Thierry Darnis
Global Vice President, Manufacturing & Engineering

Thierry Darnis, brings extensive experience in the management of major manufacturing sites for medical devices, acquired at top-tier global companies. At Medtronic and CR Bard he managed plants pursuing a successful twofold objective of increasing volumes, while optimizing costs. Before joining Biom’up, Thierry Darnis was deputy chief executive officer of Sofradim Production, a subsidiary of Medtronic plc (Dublin, Ireland / Minnesota, USA), and managed its Trevoux plant (340 employees) for more than 12 years. He has a Ph.D. in Life and Health Sciences, specialized in Biomaterials, from the University of Bordeaux II.

Simon Schwaighofer Simon Schwaighofer, MD
Vice President of Sales Europe

Simon is an electronics and biomedical engineer by training and holds an MD from Vienna University. He worked in a startup company for implantable devices where he oversaw clinical and professional education activities, held various local and global sales and business development roles at Medtronic where he also served as a medical director. Simon joined biom’up in September 2016 from Mölnlycke where he worked as general manager in different geographies for both their wound care and surgical divisions. He is responsible for the overall commercial strategy and execution, with a focus on HEMOBLAST™ Bellows, as well as the existing biosurgery portfolio.

Jean-Yves Quentel Jean-Yves Quentel
Chief Financial Officer Group

Jean-Yves Quentel has 25 years of experience as an investor, advisor and director of high technology companies in the USA and in Europe. He acquired experiences in venture capital investment, fundraising, mergers and acquisition in London. In 2010, Jean-Yves joined Atego Group Ltd, a software company for embedded systems as Administration and Finance Group Director where he was also in charge of business development. In 2012, he created Mensia Technologies, a company that produces non-invasive medical devices for the treatment of central nervous system disorders. In December 2017, Jean-Yves joined the Group as Business Development Manager and became Chief Financial Officer in 2018.